FRANKFURT, Dec 27 (Reuters) - German tycoon Adolf Merckle might have to sell his generic drugs maker Ratiopharm as part of a broader financial rescue package agreed with creditor banks, two sources close to the matter told Reuters on Saturday. It would boil down to a sale of Ratiopharm, one of the sources said. German newspaper Suedwest Presse had reported on its website on Friday that a sale of Ratiopharm was likely and was probably unavoidable, citing the head of Ratiopharm's work ...
Premium Content (PAID Subscription Required)
"Merckle may have to sell Ratiopharm -sources" is part of the paid WardsAuto Premium content. You must log in with Premium credentials in order to access this article. Premium paid subscribers also gain access to:
All of WardsAuto's reliable, in-depth industry reporting and analysis
Hundreds of downloadable data tables including:
• Global sales and production data by country
• U.S. model-line inventory data
• Engine and equipment installation rates
• WardsAuto's North America Plant by Platform forecast
• Product Cycle chart
• Interrelationships among major OEMs
• Medium- and heavy-duty truck volumes
• Historical data and much more!
For WardsAuto.com pricing and subscription information please contact
Lisa Williamson by email: email@example.com or phone: (248) 799-2642
Current subscribers, please login or CLICK for support information.